About us
Who we are
Set up in early 2017, The PTEN Research Foundation has a global scope and remit to accelerate research that will lead to a treatment for PTEN hamartoma tumour syndrome (PHTS). Our strategy is focused on three areas: funding medical research, building networks and strategic partnerships, and increasing awareness and diagnosis of PHTS.
What is PHTS?
PTEN hamartoma tumour syndrome is a rare genetic disorder caused by mutations in the PTEN gene. Children with PHTS have an increased risk of developing cancer, in particular breast, thyroid, kidney and endometrial, and often experience neurodevelopmental delay and/or autism.
There is no cure or treatment for PHTS and awareness of the condition is relatively low, presenting significant challenges to patients, families and clinicians alike.